Chemical Structure : IDOR-1117-2520
CAS No.:
2737274-49-4
IDOR-1117-2520
Catalog No.: PC-22322Not For Human Use, Lab Use Only.
IDOR-1117-2520 is a potent, selective CCR6 antagonist with IC50 of 62.9 nM for CCL20-mediated calcium flow inhibition in FLIPR calcium mobilization assay.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Purity & Documentation Purity:
>98% (HPLC)
Biological Activity
IDOR-1117-2520 is a potent, selective CCR6 antagonist with IC50 of 62.9 nM for CCL20-mediated calcium flow inhibition in FLIPR calcium mobilization assay.
IDOR-1117-2520 shows no inhibitory activity at 10 μM for any of the tested related chemokine receptors (CCR5, CCR7, CCR8, CXCR2, CXCR3, CXCR4, CXCR5, and CXCR6).
IDOR-1117-2520 has IC50 of 20 nM in functional assay of receptor internalization (RI) performed in human whole blood.
IDOR-1117-2520 inhibits β-arrestin recruitment to human CCR6 induced by the addition of CCL20.
IDOR-1117-2520 (50 nM) inhibited cell migration toward CCL20 by 40 and 50% of the maximal migration for B cells and T cells, respectively.
Physicochemical Properties
|
M.Wt
|
436.56
|
|
Formula
|
C25H32N4O3
|
|
Appearance
|
Solid
|
|
CAS No.
|
|
|
Storage
|
- Solide Powder
-
-20°C 12 Months; 4°C 6 Months
|
- In Solvent
-
-80°C 6 Months; -20°C 6 Months
|
|
Shipping
|
|
|
Solubility
|
10 mM in DMSO
|
|
Chemical Name/SMILES
|
(R)-2-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol
|
References
1. Meyer EA, et al. J Med Chem. 2024 May 10. doi: 10.1021/acs.jmedchem.4c00186.
Contact Us
sales@probechem.com
